Labcorp, with its slogan "In Pursuit of Answers," stands as a stalwart in the healthcare industry, spearheading comprehensive laboratory services globally. Founded in 1976 and headquartered in the United States, Labcorp has established itself as a crucial entity for innovation in diagnostics and drug development.
Boasting over 60,000 employees across more than 100 countries, Labcorp played a pivotal role in the approval process for over 80% of new drugs by the FDA in 2022. With its vast operational scale, the company performed more than 600 million tests worldwide, underscoring its impact and reach in the global healthcare arena.
In its most recent financial maneuver, Labcorp secured a significant $2.00 billion in Post-IPO Debt investment as of 01 September 2024, demonstrating continued investor confidence in its expansive capabilities and future growth prospects. This infusion of capital positions Labcorp to further enhance its technological advancements and service offerings.